TIGERPAW® System II Recall Litigation

The FDA issued a Class 1 recall on April 23, 2015 on theTigerPawII left atrial appendage (LAA) closure device used during open heart surgery to mitigate post-operative stroke in patients with atrial fibrillation. The recall was issued following reports the device could cause tearing of the left atrial wall along with bleeding events and possible death.

Currently, 4,154 TigerPaw II® devices - made by US- based LAAx (Livermore, CA) and sold by Maquet Medical Systems (Wayne, NJ) between April 1, 2013 and March 23, 2015 - have been recalled.

If you or a loved one had surgery where a TigerPaw System II® was used, please contact us today.